LifeScan emerges from chapter 11
We advised an ad hoc group of secured lenders in connection with LifeScan’s chapter 11 proceedings
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Novo Nordisk proposed $9.1 billion acquisition of Metsera
We are advising Novo Nordisk on the transaction
Amulet Capital Partners sale of SSI Strategy to Clinigen
We are advising Amulet Capital Partners and SSI Strategy on the sale
Strive acquisition of Semler Scientific
We are advising Strive on the acquisition
UST sale of HealthProof to Bain
We advised UST on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We advised Sycamore Partners on the transaction
Adagene $25 million strategic equity investment from Sanofi
We advised Adagene on the transaction
Nova Biomedical $2.2 billion acquisition by Advanced Instruments
We are advising Nova Biomedical on the transaction
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
Endo divestiture of International Pharmaceuticals business
We are advising Endo on the transaction